Laurel Wealth Advisors (North Carolina)’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-60
Closed -$7.37K 369
2025
Q4
$7.37K Buy
+60
New +$7.29K ﹤0.01% 506
2025
Q2
Sell
-60
Closed -$6.72K 373
2025
Q1
$6.72K Hold
60
﹤0.01% 513
2024
Q4
$5.54K Hold
60
﹤0.01% 540
2024
Q3
$5.03K Hold
60
﹤0.01% 516
2024
Q2
$4.12K Sell
60
-15
-20% -$1K ﹤0.01% 499
2024
Q1
$5.49K Buy
75
+15
+25% +$1.15K ﹤0.01% 479
2023
Q4
$4.86K Sell
60
-10
-14% -$778 ﹤0.01% 458
2023
Q3
$5.25K Hold
70
﹤0.01% 445
2023
Q2
$5.39K Hold
70
﹤0.01% 448
2023
Q1
$5.81K Hold
70
﹤0.01% 445
2022
Q4
$6.01K Hold
70
﹤0.01% 413
2022
Q3
$4K Hold
70
﹤0.01% 436
2022
Q2
$4K Buy
70
+10
+17% +$619 ﹤0.01% 465
2022
Q1
$4K Buy
+60
New +$3.83K ﹤0.01% 500
2021
Q3
Sell
-45
Closed -$3K 689
2021
Q2
$3K Buy
+45
New +$3K ﹤0.01% 609
2021
Q1
Sell
-150
Closed -$9K 668
2020
Q4
$9K Sell
150
-175
-54% -$10.6K ﹤0.01% 421
2020
Q3
$21K Hold
325
0.01% 308
2020
Q2
$25K Buy
325
+225
+225% +$17.2K 0.01% 289
2020
Q1
$7K Buy
+100
New +$6.91K ﹤0.01% 387

Other funds holding GILD

Laurel Wealth Advisors (North Carolina)'s GILD Position: Q1 2026 in Review

Laurel Wealth Advisors (North Carolina) sold out of Gilead Sciences (GILD) in Q1 2026, closing a stake of 60 shares — an estimated $7.37K sold.

Laurel Wealth Advisors (North Carolina) first reported a position in GILD in Q1 2020 and held it in 19 quarters. The position peaked at $25K in Q2 2020. 2,320 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Laurel Wealth Advisors (North Carolina) reported no remaining Gilead Sciences position as of Q1 2026 after selling out during the quarter.
  • Laurel Wealth Advisors (North Carolina) sold 60 Gilead Sciences shares in Q1 2026, an estimated $7.37K.
  • Laurel Wealth Advisors (North Carolina) first reported a position in Gilead Sciences in Q1 2020 and held it in 19 quarters.
  • Laurel Wealth Advisors (North Carolina)'s Gilead Sciences position peaked at $25K in Q2 2020.
  • 2,320 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Laurel Wealth Advisors (North Carolina)'s 13F filing for Q1 2026, filed 13 May 2026.